NASDAQ: PRE - Prenetics Global Limited

Rentabilidad a seis meses: +83.45%
Sector: Healthcare

Calendario de promoción Prenetics Global Limited

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use.

Más detalles
The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

Выручка 0.0092
EBITDA -0.0185
Число акций ао 0.01125 млрд
P/S 4.92
P/BV -3.38
EV/EBITDA 0.5737
Цена ао 3.56
ISIN KYG722451062
Сайт https://www.prenetics.com
Валюта usd
IPO date 2022-05-18
Sector Financials
Industry Insurance
Валюта отчета usd
Cambio de precio por día: +1.72% (5.23)
Cambio de precio por semana.: +37.11% (3.88)
Cambio de precio por mes: +18.22% (4.5)
Cambio de precio en 3 meses.: -6.85% (5.711)
Cambio de precio en seis meses: +83.45% (2.9)
Cambio de precio por año: +1 084.86% (0.449)
Cambio de precio en 3 años.: -46% (9.8522)
Cambio de precio desde principios de año.: +15.4% (4.61)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 2.83 6
P/BV 0.2927 10
P/E 0 0
EV/EBITDA -0.4065 0
Total: 5.75

Eficiencia

Nombre Significado Calificación
ROA, % -24.68 0
ROE, % -30.4 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 1.35

Deber

Nombre Significado Calificación
Debt/EBITDA -0.053 10
Total: 9.8

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 136.33 10
Rentabilidad Ebitda, % 141.73 10
Rentabilidad EPS, % 2964.52 10
Total: 10
Más detalles

Instituciones Volumen Compartir, %
Prudential PLC 684822 6.45
Aspex Management (HK) Ltd 346150 3.26
Nomura Holdings Inc. 193963 1.83
Aspire Private Capital, LLC 114 0
Bank of America Corporation 111 0
Wolverine Asset Management, LLC 1 0

ETF Compartir, % Rentabilidad del año, % Dividendos, %
Vanguard Intermediate-Term Bond ETF 0.01 3.0451332245786 3.45
Schwab U.S. Aggregate Bond ETF 0 -48.675717783218 3.65
Vanguard Intermediate-Term Corporate Bond ETF 0.02 4.7187981510016 4.17



Supervisor Título profesional Pago año de nacimiento
Mr. Hoi Chun Lo Chief Financial Officer N/A 1985 (39 años)
Dr. Yung Ho Wong DPHIL Chief Technology Officer N/A 1982 (42 año)
Ms. Samantha Kwok Chief of Staff to Group CEO & Vice President of People & Operations N/A
Dr. Senthil Sundaram M.D. Chief Clinical Officer N/A 1974 (50 años)
Mr. Joel Neoh Chief Consumer Officer & CEO for CircleDNA N/A 1984 (40 años)
Mr. Sheng Wu Yeung Co-Founder, Chairperson & CEO N/A 1979 (45 años)
Dr. Chi Hung Tzang Ph.D. Co-Founder & Chief Scientific Officer N/A 1974 (50 años)
Mr. Walt Ling Chief Executive Officer of ACT Genomics N/A

DIRECCIÓN: Hong Kong, Quarry Bay, Unit 701-706. K11 Atelier King’s Road - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.prenetics.com